Endothelial Cell (EC) Differentiation Service from iPSC

Endothelial Cell (EC) Differentiation from iPSCs - Service Details

iPSC derived endothelial cell (EC) differentiation refers to a process of differentiating induced pluripotent stem cells (iPSCs) into endothelial cells, which are specialized cells that line the inner surface of blood vessels and play important roles in vascular development, maintenance, and function.

The differentiation of iPSCs into endothelial cells involves a series of steps that mimic the natural development of endothelial cells from embryonic stem cells. This process typically involves the use of specific growth factors and culture conditions to promote the formation of endothelial cells from iPSCs.

The resulting iPSC-derived endothelial cells can be used for a variety of research applications, such as drug screening, disease modeling, and tissue engineering. They can also be used to study the molecular and cellular mechanisms underlying endothelial cell function and dysfunction in various diseases, such as cardiovascular disease and cancer.

Overall, the differentiation of iPSCs into endothelial cells provides a valuable tool for researchers to investigate the complex biology of endothelial cells and develop new treatments for diseases that involve endothelial dysfunction.

Standard Packaging:

• Ship 1-2 million iPS cells (1-2 cryovials; 1 million cells/vial); OR
  • With pathogen and SARS-CoV-2 test results
    • Optional Pathogen Testing Service is available
• Select one of our Control iPS Cell Lines; OR
• Let ASC generate your iPSCs from your human or non-human samples

Standard Deliverables:

• 2 million differentiated cells 
• Data & Report

Standard Workflow and Timeline:

Turnaround time: 3 weeks